| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.39 | 0.09 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |